GEN5d
AI Expedites Motor Neuron Analysis and Screening in ALS Research
Analysis of the cultured LMNs showed that in addition to maintaining ALS cellular markers, their survival rates mimicked ALS ...
GEN5d
Mechanism for Cellular RNA’s Role in Antiviral Immune Response Uncovered
The data shows that RNA interacts with a mitochondrial protein complex to trigger immune response pathways when viral RNA is ...
GEN6d
Akamis Bio Raises $60 Million for Cancer Gene Therapy, Signs Licensing Deal with Xuanzhu Biopharma
The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...
GEN4d
StockWatch: Wall Street’s Leaders and Laggards of 2024
GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...
GEN6d
Mechanisms Underlying Sjögren’s Disease Outlined in Mice; Existing Drug Shows Therapeutic Promise
The newly reported study showed that impaired regulatory T cells are a critical contributing factor to Sjögren’s disease in ...
GEN6d
Scinai Immunotherapeutics Establishes U.S. CDMO Subsidiary
The U.S. CDMO recently signed its first contract with a customer, Serpin Pharma, to support their clinical manufacturing.
GEN6d
Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes
Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human organoids.
GEN6d
Uncovering Craniopharyngioma’s Growth Mechanism May Identify New Therapy
Researchers reveal new insights on the growth of craniopharyngioma and identified a potential therapeutic treatment.